BioPorto Highlights FDA-Cleared ProNephro AKI Test Amid Growing Focus on Kidney Injury Biomarkers
Company showcases FDA-cleared ProNephro AKI test as acute kidney injury remains key focus for laboratory medicine professionals.
Company showcases FDA-cleared ProNephro AKI test as acute kidney injury remains key focus for laboratory medicine professionals.
Researchers have developed a novel metasurface biosensor platform that improves the detection and monitoring of chronic kidney disease.
A simple blood test may predict the risk of progressive heart and kidney disease in people with Type 2 diabetes and kidney disease.
Natera detailed a paper highlighting the clinical utility of its comprehensive kidney gene panel Renasight in aiding kidney disease diagnosis.
Read MoreBroad-based genetic testing gives clinicians better insights into chronic kidney disease, improving the odds of a good transplant outcome.
Read MoreA personalized approach to kidney disease screening for type 1 diabetes patients may reduce the time chronic kidney disease goes undetected.
Read MoreA team of researchers identified a new technique that can detect damage to children’s kidneys earlier than current tests
Read MoreAcute kidney injury is common in patients in the ICU. Predicting which patients are at risk helps clinicians take preventive measures.
Read MoreResearch shows that removing a race modifier from a formula used to diagnose kidney disease may lead to equitable care for Black patients.
Read MoreMillions of COVID patients may have undiagnosed acute kidney injury, a condition where the kidneys fail to filter waste from the blood.
Read MoreResearchers established the inherited condition, TULP3-related ciliopathy, which causes kidney and liver failure in children and adults.
Read MoreIn 2010, scientists discovered that African Americans born with a certain gene have a higher risk for experiencing chronic kidney disease.
Read MoreNova Biomedical’s tool improves kidney care through improved kidney function screening and early kidney disease detection.
Read MoreSelfDecode is providing people with the opportunity to gain insight regarding their genetic predisposition for health issues.
Read MoreMetabolites in the blood whose levels are altered by coffee consumption and may contribute to risk of developing chronic kidney disease.
Read MoreGiving a big penalty to an algorithm for false negatives results in much better precision, UJ researchers find.
Read MoreThe National Kidney Foundation and the American Society of Nephrology have outlined a new race-free approach to diagnosing kidney disease.
Read MoreDespite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a protein in the urine test.
Read More